We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

U:NYSEUnity Software Inc. Analysis

Data as of 2026-09-09 - not real-time

$42.78

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Unity Software Inc. is priced at $42.78 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 34.4%. With RSI at 56.5 the momentum picture is neutral, alongside a bearish MACD signal. Watch $40.22 as support and $48.46 as the nearer resistance level.
Valuation screens as fair: a P/E of 24.6 sits below the sector average of 33.3. The average analyst target implies 15.5% above today's level. Revenue is growing at 23.9% on a -29.0% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 56.7%, a beta of 2.13 and a maximum drawdown of 65.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Shares of interactive software platform Unity NYSE:U jumped 3.Interactive software platform Unity NYSE:U reported Q2 CY2026 results , with sales up 23.Yahoo Finance1monUnity Software Inc U Q2 2026 Earnings Call Highlights: Record Revenue and Profitability SurgeThe above...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 32.11
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 24.6 versus sector average of 33.3
  • Trading above the 200-day average of 32.11

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 24.6 versus sector average of 33.3
  • Negative profit margin of -29.0%
  • Analyst targets imply +15.5% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth23.90%
Profit Margin-28.97%
P/E Ratio24.6
ROE-17.38%
ROA-3.12%
Debt/Equity70.18
P/B Ratio6.2
Op. Cash Flow$553.7M
Free Cash Flow$599.6M
Industry P/E33.3

Technical Analysis

TrendBullish
RSI56.5
Support$40.22
Resistance$48.46
MA 20$44.24
MA 50$37.14
MA 200$32.11
MACDBearish
VolumeDecreasing
Fear & Greed Index92.41

Valuation

Fair Value$45.14
Target Price$49.39
Upside/Downside15.45%
GradeFair
TypeGrowth

Risk Assessment

Beta2.13
Volatility56.65%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.